Top

Published in:

01-03-2020 | Salbutamol | Case report

Ipratropium-bromide/salbutamol

Atrial fibrillation and ventricular tachycardia: 2 case reports

Published in: Reactions Weekly | Issue 1/2020

Excerpt

In a study of 30 patients aged 65−70 years, an elderly man and an elderly woman [exact ages not stated] were described, who developed atrial fibrillation and ventricular tachycardia, respectively during treatment with ipratropium bromide and salbutamol for chronic obstructive pulmonary disease (COPD) [routes, durations of treatments to reactions onsets and outcomes not stated]. …

Sethi R, et al. Salbutamol and ipratropium bromide are high risk factors for atrial arrhythmias in patients with COPD and CVS diseases. European Respiratory Journal 54 (Suppl. 63): PA2462, Sep 2019. Available from: URL: http://doi.org/10.1183/13993003.congress-2019.PA2462 [abstract]

Title: Ipratropium-bromide/salbutamol
Atrial fibrillation and ventricular tachycardia: 2 case reports
Publication date: 01-03-2020
Publisher: Springer International Publishing
Keywords: Salbutamol
Ventricular Tachycardia
Atrial Fibrillation
Ipratropium
Chronic Obstructive Lung Disease
Published in: Reactions Weekly / Issue 1/2020
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-020-75929-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Ipratropium-bromide/salbutamol

Atrial fibrillation and ventricular tachycardia: 2 case reports

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2020

Lansoprazole

Ipragliflozin

Infliximab

Immunosuppressants

Enbucrilate/ethiodized-oil

Enoxaparin-sodium